Survival in selected patients with gram-negative sepsis after adjunctive therapy with HA-1A.
van Dissel
J T
JT
van Furth
R
R
Compier
B A
BA
Feuth
H D
HD
Frolich
M
M
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D004731:Endotoxins / Q000276:immunology*; D005260:Female; D016905:Gram-Negative Bacterial Infections / Q000401:mortality / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012772:Shock, Septic / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate
D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D004731:Endotoxins; C068069:nebacumab